--°C
Loading...
Listen to Article
2 min read
80%

New Delhi: The Russian Direct Investment Fund (RDIF) stated on Sunday that the Sputnik V vaccine demonstrated a higher or equal tolerability profile in people above the age of 60 years, during inoculation campaign in San-Marino.

As per an official release, the Sputnik V vaccine has shown strong efficacy against hospitalization and tolerability among the elderly population in the country.

The study was conducted among people in San Marino who received two doses of Sputnik V beginning March 4 to April 8. The results of the study were published in EClinicalMedicine, an open-access clinical journal published by The Lancet.

FOLLOW US F
POPULAR
FEATURE
TRENDY
Happy Friendship Day 2025: Celebrating the Bonds That Unite Us
Kickstart Your Day with Ghee Water: A Time-Tested Wellness Ritual
India's Multi-Billion Dollar Chinese Money Laundering Syndicate
Divya Deshmukh Triumphs Over  Koneru Humpy to Win Women’s World Cup and Earn Grandmaster Title
Too Much Sleep? Here's Why Oversleeping Could Be a Warning Sign, Not Just a Habit
Love Ice Cream in Summer? Here’s How It Might Be Hurting Your Health